The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.
VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.
World Sleep 2022 | Excessive daytime sleepiness in obstructive sleep apnea
Winfried Randerath, MD, FCCP, Centre of Sleep Medicine and Respiratory Care, Solingen, Germany, speaks on the relevance of excessive daytime sleepiness (EDS) as a disease marker in obstructive sleep apnea (OSA). Prof. Randerath explains that while EDS is often a diagnostic factor in OSA, it is reported in about 50% of patients so it is important to monitor other symptoms. EDS monitoring is essential as it is associated with poorer patient prognosis in OSA comorbidities and treatment-resistant EDS can be a sign of underlying conditions or poor therapeutic response. This interview was recorded at the World Sleep Congress 2022 in Rome, Italy.
Disclosures
Funding from Bioprojet and Jazz
